Roger: The uptrend of NMPS is still intact. After building a bottom for the past four months, it is creeping slowly by breaking one ascending triangle at a time. Now, it is above the all important 200-DMA with some breathing room to spare and long term investors should feel good at this juncture. However, unlike 9 months ago that time was on the side of the investors, now time is running out fast.
As predicted, Clinton will win by a landslide. Why? The market told me so when I wrote my Vision (#144): Clinton has been predetermined to win big so that the market will slide next year. The market calls the shot, and NOT Clinton. That's the raw power of technical analysis that you are witnessing in action.
Again as predicted, the market is moving up towards the election. Why? I mentioned several times in the past that time was runnig out for the market makers and they HAD to take the market up within the election time window. That's another example tea leaf reading in action.
Again and again as predicted, the market will rally towards the December/January time frame for an early January effect. Why? The momentum of the landslide victory, the euphoria of the mass psychology, the crossing of the 6000 marks and the rising consummer sentiment will create a temporary bubble that will burst shortly after the inaugural ball. That will be further proof of the prowess of the technical leaves that I have been digesting.
I spoke to Chubb and Co many times in the past and urged them to cash in with the momentum of the FDA approval in January. They did, only eight months later in September:
1.Fahnstock recommendation
2.Spain distribution pact
3.Far East dsitribution pact
4.Genesis Merchant push
5.Colon cancer trial
Imagine, if these jokers were doing their job and did all these in February or March, NMPS would have a decent shot to the moon. Timing again is everthing. Now that they have missed the critical time window, and they have to race against time to take the price up. Please note that all of the above concentrated actions in one month fails to rocket NMPS to the $15 range is mildly disappointing. I guess for a young R/D company, they still have a lot to learn in PR and marketing. The coming early January effect will have a positive impact to its share price. How much impact? It all depends on their PR work. (Please don't expect too much in sales and earnings as they are years away from profitability, and by then, we may have found a cure for cancer)
I better go hiding again. There are so much to do and so little time left. Being alive is one big accomplishment.
Best wishes from a mad monk. |
